Biographies
Peter Barry
Consultant Surgeon, The Royal Marsden, UK
Mr Barry qualified from University of Sydney, Australia and obtained a Fellowship in Surgical Oncology in sarcoma, melanoma and breast cancer at The Royal Marsden from 2000–02. He now focuses on breast oncoplastic techniques and reconstructive options following cancer surgery as well as preventative surgery for high-risk women and has been a consultant surgeon at The Breast Unit, Royal Marsden since 2012. He introduced the chest wall perforator flap service for breast conservation and has led development of targeted axillary dissection. He has an interest in translational medicine with publications on tumour evolution and heterogeneity in breast cancer using ctDNA and immunophenotyping markers. He also leads development and trialing of new devices in surgery.
Dr Sara A Hurvitz
Professor of Medicine, University of Washington School of Medicine
Professor of Medicine, Fred Hutchinson Cancer Center
Dr Hurvitz serves as Division Head of Hematology/Oncology at University of Washington School of Medicine and as Senior Vice President of the Clinical Research Division at the Fred Hutchinson Cancer Center, where she holds the Smith Family Endowed Chair in Women’s Health. Dr Hurvitz earned her MD from the University of Southern California. She served internship/residency at UCLA, was Chief Resident of internal medicine and completed a hematology-oncology fellowship at UCLA in 2006. Dr Hurvitz received board-certification in internal medicine, hematology, and medical oncology. She led the breast cancer clinical trials program at UCLA for 17 years and was Medical Director of the Jonsson Comprehensive Cancer Center until 2023 when she accepted a leadership position at UW/FHCC. Dr Hurvitz has won numerous awards over the past few years, among them the Marni Levine Memorial Breast Cancer Research Award 2008 through 2015 and the European Society of Medical Oncology Breast Cancer Award in 2023. She has an active clinical practice specialising in the treatment of women with breast cancer. She is involved in designing, implementing and leading multiple national and international clinical trials testing new targeted therapies.
Dr Belinda Yeo
Deputy Director of Medical Oncology, Austin Health, Melbourne
Clinician Scientist, Olivia Newton-John Cancer Research Institute
Belinda Yeo is a Medical Oncologist specialising in breast cancer and the Deputy Director of Medical Oncology at Austin Health in Melbourne. She is also a Clinician Scientist at the Olivia Newton-John Cancer Research Institute.
After training in Sydney, she joined the Breast Unit at The Royal Marsden Hospital in London as a Clinical and Research Fellow. She completed a Master’s Degree at The University of London and The Institute of Cancer Research in novel genomic and non-molecular breast cancer risk assays.
Belinda was co-lead of the VCCC Research and Education Stream for Breast Cancer until 2023. She actively supervises PhD students, serves as a clinical trial investigator, and continues her translational research at the ONJ Centre, focusing on improving personalised care and minimising treatment toxicities for patients with breast cancer.